BC Platforms, a world leader in providing powerful genomic data management and analysis solutions, today announced the appointment of Chief Commercial Officer (CCO), North America, Weston Fox to its Management Team. Mr. Fox, who has extensive experience and networks in Healthcare and Life Science, will work closely with the company’s established commercial team, to lead the business […]
BC Platforms, a global leader in clinical and genomic data management, analytics and access, today announced it is providing its discovery and research platform BC|INSIGHT to enable ground-breaking medical research into the early diagnosis of lung cancer in order to save lives. Lung cancer is the biggest cause of cancer death in the UK and […]
Award-winning Genedata Imagence HCS imaging enterprise software rolled out to AstraZeneca R&D sites globally with the aim of improving the identification of new drug candidates and drug targets Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Genedata Imagence®, its deep learning-based image analysis software solution, has […]
With a growing data partner network, BC Platforms enables rapid access to longitudinal clinical and genomic data across a catchment of over 20M patient lives The Discovery and Research Platform transforms global clinical practice by enabling rapid insights across user cases, from cancer to coronavirus BC Platforms, a global leader in clinical and genomic data […]
Emedgene’s artificial intelligence capabilities enhance Illumina’s TruSight™ Software Suite providing a scalable and streamlined solution for rare disease interpretation PALO ALTO, California — Emedgene, a leading precision medicine intelligence company, announces a non-exclusive partnership with Illumina Inc. and the integration of automated interpretation into Illumina’s TruSight™ Software Suite for rare genetic diseases. Emedgene’s Clinical Rare […]
Certara, Inc. (“Certara”), a global leader in biosimulation by 2019 revenue, today announced that on December 15, 2020, it closed its upsized initial public offering of 33,413,250 shares of common stock at $23.00 per share. The closing includes 4,358,250 shares sold upon full exercise of the underwriters’ option to purchase additional shares of common stock. […]
The partnership will allow for a seamless MiXCR integration into the IGX Platform, allowing MiXCR users to leverage its intuitive user interface and unique data management capabilities ‘s-Hertogenbosch (The Netherlands) and Solana Beach, CA (United States) – ENPICOM BV, an innovative bioinformatics software engineering company, and MiLaboratories LLC, a technology leader in profiling the mammalian […]
Qlucore, leading software provider of powerful visualization-based bioinformatics data analysis tools for research and precision diagnostics, is working with leading scientific experts at Lund University (Sweden), Gothenburg University (Sweden) and in China to develop new diagnostics methods and software solutions to significantly improve disease stratification and treatment selection of patients diagnosed with cancer. A recent […]
SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced its clinical informatics platform Alissa Interpret has been adopted by the North West Genomic Laboratory Hub (NW GLH) based in Manchester and Liverpool, part of Manchester University NHS Foundation Trust, England. The NW GLH and its partners are responsible for delivering genomic testing across the whole of the North […]
PRINCETON, NJ. – Certara, Inc. (“Certara”) today announced the launch of its initial public offering of 24,390,000 million shares of its common stock pursuant to a registration statement filed with the Securities and Exchange Commission. Certara is offering 14,630,000 shares of common stock and certain selling stockholders are offering 9,760,000 shares of common stock in […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
